For the Inventor, By the Inventor

Enter assignee name

Les Ulis, France

Laboratoire Francais Du Fractionnement Et Des Biotechnologies

USPTO Granted Patents = 97

CIPO Patents = 19

EPO Patents = 75

Trademarks = 10

Forward Citations = 284

Loading Chart...

Loading Chart...

106 inventors (with patents filed for the assignee):

Christophe De Romeuf (21 out of 30 patents)

Nicolas Bihoreau (19 out of 24 patents)

Emmanuel Nony (16 out of 29 patents)

4. Dominique Bourel (15 out of 21 patents)

5. Abdessatar Chtourou (11 out of 14 patents)

6. Christine Gaucher (10 out of 11 patents)

7. Roland Beliard (8 out of 14 patents)

8. Annie Bardat (8 out of 9 patents)

9. Sylvie Jorieux (8 out of 8 patents)

10. Christian Behrens (8 out of 11 patents)

11. Alexandre Fontayne (7 out of 8 patents)

12. Philippe Mondon (6 out of 7 patents)

13. Sami Chtourou (6 out of 7 patents)

14. Roland Schmitthaeusler (6 out of 12 patents)

15. Arnaud Glacet (6 out of 9 patents)

Core Competencies:

Anti-Fibrinogen Aptamers

Immunotherapy Fc Fragments

Sampling Device

Anti-CD20 Antibody Compositions

Fc Mutants

Cryopreservation of Cells

Glycols as Pathogen Inactivating Agents

Affinity Chromatography Matrix

Transgenic Factor VII

Monoclonal Antibodies

ADCC-Optimized Antibodies

Therapeutic Solutions Storage

97 patents: Sort by Forward Citations

1. 12281312 - Anti-fibrinogen aptamers (2025-04-21),

2. 12247076 - Use of modified Fc fragments in immunotherapy (2025-03-11),

3. 12025539 - Sampling device for sampling from a surface of an industrial vessel without requiring a person to descend into an industrial vessel, using a swab (2024-07-02),

4. 11965032 - Anti-CD20 antibody compositions (2024-04-23),

5. 11884740 - Anti-CD20 antibody compositions (2024-01-30),

6. 11814439 - Anti-CD20 antibody compositions (2023-11-14),

7. 11814438 - Fc mutants with improved functional activity (2023-11-14),

8. 11807689 - Anti-CD20 antibody compositions (2023-11-07),

9. 11785937 - Method for the cryopreservation of cells for therapeutic purposes (2023-10-17),

10. 11649271 - Fc mutants with modified functional activity (2023-05-16),

11. 11553712 - Glycols as pathogen inactivating agents (2023-01-17),

12. 11412730 - Method for the cryopreservation of cells for therapeutic purposes (2022-08-16),

13. 11254920 - Factor VII composition having a substantially homogenous isoelectric point (2022-02-22),

14. 11091552 - Specific binding molecule directed against galectin-3 protein (2021-08-17),

15. 10966977 - Combination of anti-CD20 antibody, P13 kinase-delta selective inhibitor, and BTK inhibitor to treat b-cell proliferative disorders (2021-04-06),

LABORATOIRE FRANCAIS DU FRACTIONNEMENT ET DES BIOTECHNOLOGIES (LFB) is a leading French biotechnology company specializing in the fractionation of plasma and the development, production, and marketing of plasma-derived therapeutic products. With over 100 years of history, LFB is committed to improving the healthcare of patients through innovative biotechnological solutions. Visit their website for more information.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

97 Patents

#1 in Les Ulis

#272 in France

#7,772 in the World

Les Ulis, France

Laboratoire Francais Du Fractionnement Et Des Biotechnologies

Forward Citations = 284

106 inventors:

Christophe De Romeuf (21 out of 30 patents)

Nicolas Bihoreau (19 out of 24 patents)

Emmanuel Nony (16 out of 29 patents)

4. Dominique Bourel (15 out of 21 patents)

5. Abdessatar Chtourou (11 out of 14 patents)

Please report any incorrect information to support@idiyas.com

Loading…